Latest Content

My intent in writing this blog is to make sure that other people whose loved ones have cancer understand just how amazing it is to be given short respites from being a patient.

Six-time cancer survivor encourages patients to trust doctors, lean on support, and save energy for moving forward instead of fear.

The U.S. FDA has granted orphan drug designation to HCB101, an investigational immunotherapy, for the treatment of gastric cancer.

There are a number of pulmonary embolism warning signs patients with cancer and their caregivers should watch for.

Phase 2 study shows proton therapy kept 79.1% of patients progression free at five years and limited severe side effects compared with older radiation data.

Exploring the importance of heart health in cancer survivorship, we spoke with experts and survivors.

Heather Quintana Suchan says early biomarker testing at diagnosis helped match her to Rybrevant and urges patients to personalize care and stay active during treatment.

A liver cancer survivor shares transplant insights, dispels living donor myths and urges patients to advocate for informed, hopeful care.

Heather Quintana Suchan, a nonsmoker with stage 4 lung cancer, credits genomic testing and Rybrevant and urges others not to ignore mild symptoms.

Dr. Sue Hwang, a radiation oncologist and breast cancer survivor, sheds light on the reality of cancer survivorship.

A Clayman Thyroid Center report aims to clarify FDA safety warnings, finding no evidence that GLP-1 drugs like Ozempic cause common thyroid cancers.

The FDA has accepted a sNDA for Ameluz topical gel, used in combination with the RhodoLED red-light lamp series, for superficial basal cell carcinoma treatment.

The U.S. Food and Drug Administration has approved a new treatment for adults with locally advanced pancreatic cancer.